NCT00458341 - A Study of Ataluren in Pediatric Participants With Cystic Fibrosis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 23, 2007

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions

Cystic Fibrosis

Interventions

DRUG

Ataluren

Ataluren will be provided as a vanilla-flavored powder to be mixed with water, milk, or apple juice. Participants are to receive a total of 42 doses of ataluren during each cycle, for a total of 84 doses of ataluren in both cycles.

Trial Locations (3)

1020

Reine Fabiola Hospital, Brussels

3000

UZ Gasthuisberg Leuven, Leuven

75015

Hopital Necker Enfants Malades, Paris